Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Gastro Esophageal Reflux Disease Drug and Devices market report explains the definition, types, applications, major countries, and major players of the Gastro Esophageal Reflux Disease Drug and Devices market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Ironwood Pharmaceuticals Inc
Cempra Inc
Merck & Co Inc
Valeant Pharmaceuticals International Inc
Medigus Ltd
Pfizer Inc
AstraZeneca PLC
Johnson & Johnson
Mederi Therapeutics Inc
EndoStim Inc
Medtronic Inc
EndoGastric Solutions Inc
Novartis AG
Takeda Pharmaceutical Company Limited
Teva Pharmaceuticals Industries Limited
GlaxoSmithKline Plc
Boston Scientific Corporation
Torax Medical
Jeil pharmaceutical Co Ltd
By Type:
Medigus Ultrasonic Surgical Endostapler
LINX Management System
Stretta Therapy
Bravo Reflux Testing System
Digitrapper Reflux Testing System
Others
By End-User:
Hospitals
Clinics
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Gastro Esophageal Reflux Disease Drug and Devices Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Gastro Esophageal Reflux Disease Drug and Devices Outlook to 2028- Original Forecasts
-
2.2 Gastro Esophageal Reflux Disease Drug and Devices Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Gastro Esophageal Reflux Disease Drug and Devices Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Gastro Esophageal Reflux Disease Drug and Devices Market- Recent Developments
-
6.1 Gastro Esophageal Reflux Disease Drug and Devices Market News and Developments
-
6.2 Gastro Esophageal Reflux Disease Drug and Devices Market Deals Landscape
7 Gastro Esophageal Reflux Disease Drug and Devices Raw Materials and Cost Structure Analysis
-
7.1 Gastro Esophageal Reflux Disease Drug and Devices Key Raw Materials
-
7.2 Gastro Esophageal Reflux Disease Drug and Devices Price Trend of Key Raw Materials
-
7.3 Gastro Esophageal Reflux Disease Drug and Devices Key Suppliers of Raw Materials
-
7.4 Gastro Esophageal Reflux Disease Drug and Devices Market Concentration Rate of Raw Materials
-
7.5 Gastro Esophageal Reflux Disease Drug and Devices Cost Structure Analysis
-
7.5.1 Gastro Esophageal Reflux Disease Drug and Devices Raw Materials Analysis
-
7.5.2 Gastro Esophageal Reflux Disease Drug and Devices Labor Cost Analysis
-
7.5.3 Gastro Esophageal Reflux Disease Drug and Devices Manufacturing Expenses Analysis
8 Global Gastro Esophageal Reflux Disease Drug and Devices Import and Export Analysis (Top 10 Countries)
-
8.1 Global Gastro Esophageal Reflux Disease Drug and Devices Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Gastro Esophageal Reflux Disease Drug and Devices Export by Region (Top 10 Countries) (2017-2028)
9 Global Gastro Esophageal Reflux Disease Drug and Devices Market Outlook by Types and Applications to 2022
-
9.1 Global Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Medigus Ultrasonic Surgical Endostapler Consumption and Growth Rate (2017-2022)
-
9.1.2 Global LINX Management System Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Stretta Therapy Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Bravo Reflux Testing System Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Digitrapper Reflux Testing System Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Gastro Esophageal Reflux Disease Drug and Devices Market Analysis and Outlook till 2022
-
10.1 Global Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.2.2 Canada Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.2.3 Mexico Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.3.2 UK Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.3.3 Spain Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.3.4 Belgium Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.3.5 France Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.3.6 Italy Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.3.7 Denmark Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.3.8 Finland Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.3.9 Norway Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.3.10 Sweden Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.3.11 Poland Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.3.12 Russia Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.3.13 Turkey Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.4.2 Japan Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.4.3 India Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.4.4 South Korea Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.4.5 Pakistan Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.4.6 Bangladesh Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.4.7 Indonesia Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.4.8 Thailand Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.4.9 Singapore Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.4.10 Malaysia Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.4.11 Philippines Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.4.12 Vietnam Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.5.2 Colombia Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.5.3 Chile Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.5.4 Argentina Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.5.5 Venezuela Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.5.6 Peru Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.5.7 Puerto Rico Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.5.8 Ecuador Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.6.2 Kuwait Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.6.3 Oman Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.6.4 Qatar Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.6.5 Saudi Arabia Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.6.6 United Arab Emirates Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.7.2 South Africa Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.7.3 Egypt Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.7.4 Algeria Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
-
10.8.2 New Zealand Gastro Esophageal Reflux Disease Drug and Devices Consumption (2017-2022)
11 Global Gastro Esophageal Reflux Disease Drug and Devices Competitive Analysis
-
11.1 Ironwood Pharmaceuticals Inc
-
11.1.1 Ironwood Pharmaceuticals Inc Company Details
-
11.1.2 Ironwood Pharmaceuticals Inc Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Ironwood Pharmaceuticals Inc Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
11.1.4 Ironwood Pharmaceuticals Inc Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Cempra Inc
-
11.2.1 Cempra Inc Company Details
-
11.2.2 Cempra Inc Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Cempra Inc Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
11.2.4 Cempra Inc Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Merck & Co Inc
-
11.3.1 Merck & Co Inc Company Details
-
11.3.2 Merck & Co Inc Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Merck & Co Inc Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
11.3.4 Merck & Co Inc Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Valeant Pharmaceuticals International Inc
-
11.4.1 Valeant Pharmaceuticals International Inc Company Details
-
11.4.2 Valeant Pharmaceuticals International Inc Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Valeant Pharmaceuticals International Inc Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
11.4.4 Valeant Pharmaceuticals International Inc Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Medigus Ltd
-
11.5.1 Medigus Ltd Company Details
-
11.5.2 Medigus Ltd Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Medigus Ltd Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
11.5.4 Medigus Ltd Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Pfizer Inc
-
11.6.1 Pfizer Inc Company Details
-
11.6.2 Pfizer Inc Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Pfizer Inc Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
11.6.4 Pfizer Inc Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 AstraZeneca PLC
-
11.7.1 AstraZeneca PLC Company Details
-
11.7.2 AstraZeneca PLC Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 AstraZeneca PLC Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
11.7.4 AstraZeneca PLC Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Johnson & Johnson
-
11.8.1 Johnson & Johnson Company Details
-
11.8.2 Johnson & Johnson Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Johnson & Johnson Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
11.8.4 Johnson & Johnson Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Mederi Therapeutics Inc
-
11.9.1 Mederi Therapeutics Inc Company Details
-
11.9.2 Mederi Therapeutics Inc Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Mederi Therapeutics Inc Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
11.9.4 Mederi Therapeutics Inc Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 EndoStim Inc
-
11.10.1 EndoStim Inc Company Details
-
11.10.2 EndoStim Inc Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 EndoStim Inc Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
11.10.4 EndoStim Inc Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Medtronic Inc
-
11.11.1 Medtronic Inc Company Details
-
11.11.2 Medtronic Inc Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Medtronic Inc Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
11.11.4 Medtronic Inc Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 EndoGastric Solutions Inc
-
11.12.1 EndoGastric Solutions Inc Company Details
-
11.12.2 EndoGastric Solutions Inc Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 EndoGastric Solutions Inc Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
11.12.4 EndoGastric Solutions Inc Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Novartis AG
-
11.13.1 Novartis AG Company Details
-
11.13.2 Novartis AG Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Novartis AG Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
11.13.4 Novartis AG Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Takeda Pharmaceutical Company Limited
-
11.14.1 Takeda Pharmaceutical Company Limited Company Details
-
11.14.2 Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
11.14.4 Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Teva Pharmaceuticals Industries Limited
-
11.15.1 Teva Pharmaceuticals Industries Limited Company Details
-
11.15.2 Teva Pharmaceuticals Industries Limited Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Teva Pharmaceuticals Industries Limited Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
11.15.4 Teva Pharmaceuticals Industries Limited Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 GlaxoSmithKline Plc
-
11.16.1 GlaxoSmithKline Plc Company Details
-
11.16.2 GlaxoSmithKline Plc Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 GlaxoSmithKline Plc Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
11.16.4 GlaxoSmithKline Plc Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Boston Scientific Corporation
-
11.17.1 Boston Scientific Corporation Company Details
-
11.17.2 Boston Scientific Corporation Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Boston Scientific Corporation Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
11.17.4 Boston Scientific Corporation Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 Torax Medical
-
11.18.1 Torax Medical Company Details
-
11.18.2 Torax Medical Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 Torax Medical Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
11.18.4 Torax Medical Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 Jeil pharmaceutical Co Ltd
-
11.19.1 Jeil pharmaceutical Co Ltd Company Details
-
11.19.2 Jeil pharmaceutical Co Ltd Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 Jeil pharmaceutical Co Ltd Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
11.19.4 Jeil pharmaceutical Co Ltd Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
11.19.5 Recent Research and Development Strategies
12 Global Gastro Esophageal Reflux Disease Drug and Devices Market Outlook by Types and Applications to 2028
-
12.1 Global Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Medigus Ultrasonic Surgical Endostapler Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global LINX Management System Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Stretta Therapy Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Bravo Reflux Testing System Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Digitrapper Reflux Testing System Consumption Forecast and Growth Rate (2022-2028)
-
12.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Gastro Esophageal Reflux Disease Drug and Devices Market Analysis and Outlook to 2028
-
13.1 Global Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.2.2 Canada Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.2.3 Mexico Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.3.2 UK Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.3.3 Spain Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.3.4 Belgium Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.3.5 France Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.3.6 Italy Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.3.7 Denmark Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.3.8 Finland Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.3.9 Norway Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.3.10 Sweden Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.3.11 Poland Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.3.12 Russia Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.3.13 Turkey Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.4.2 Japan Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.4.3 India Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.4.4 South Korea Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.4.8 Thailand Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.4.9 Singapore Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.4.11 Philippines Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.5.2 Colombia Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.5.3 Chile Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.5.4 Argentina Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.5.6 Peru Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.6.3 Oman Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.6.4 Qatar Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.7.2 South Africa Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.7.3 Egypt Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.7.4 Algeria Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Gastro Esophageal Reflux Disease Drug and Devices
-
Figure of Gastro Esophageal Reflux Disease Drug and Devices Picture
-
Table Global Gastro Esophageal Reflux Disease Drug and Devices Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Gastro Esophageal Reflux Disease Drug and Devices Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Medigus Ultrasonic Surgical Endostapler Consumption and Growth Rate (2017-2022)
-
Figure Global LINX Management System Consumption and Growth Rate (2017-2022)
-
Figure Global Stretta Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Bravo Reflux Testing System Consumption and Growth Rate (2017-2022)
-
Figure Global Digitrapper Reflux Testing System Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Gastro Esophageal Reflux Disease Drug and Devices Consumption by Country (2017-2022)
-
Table North America Gastro Esophageal Reflux Disease Drug and Devices Consumption by Country (2017-2022)
-
Figure United States Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure Canada Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure Mexico Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Table Europe Gastro Esophageal Reflux Disease Drug and Devices Consumption by Country (2017-2022)
-
Figure Germany Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure UK Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure Spain Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure Belgium Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure France Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure Italy Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure Denmark Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure Finland Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure Norway Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure Sweden Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure Poland Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure Russia Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure Turkey Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Table APAC Gastro Esophageal Reflux Disease Drug and Devices Consumption by Country (2017-2022)
-
Figure China Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure Japan Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure India Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure South Korea Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure Thailand Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure Singapore Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure Philippines Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Table South America Gastro Esophageal Reflux Disease Drug and Devices Consumption by Country (2017-2022)
-
Figure Brazil Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure Colombia Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure Chile Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure Argentina Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure Peru Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Table GCC Gastro Esophageal Reflux Disease Drug and Devices Consumption by Country (2017-2022)
-
Figure Bahrain Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure Oman Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure Qatar Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Table Africa Gastro Esophageal Reflux Disease Drug and Devices Consumption by Country (2017-2022)
-
Figure Nigeria Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure South Africa Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure Egypt Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure Algeria Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Table Oceania Gastro Esophageal Reflux Disease Drug and Devices Consumption by Country (2017-2022)
-
Figure Australia Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Gastro Esophageal Reflux Disease Drug and Devices Consumption and Growth Rate (2017-2022)
-
Table Ironwood Pharmaceuticals Inc Company Details
-
Table Ironwood Pharmaceuticals Inc Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ironwood Pharmaceuticals Inc Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
Table Ironwood Pharmaceuticals Inc Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
Table Cempra Inc Company Details
-
Table Cempra Inc Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cempra Inc Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
Table Cempra Inc Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
Table Merck & Co Inc Company Details
-
Table Merck & Co Inc Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Inc Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
Table Merck & Co Inc Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
Table Valeant Pharmaceuticals International Inc Company Details
-
Table Valeant Pharmaceuticals International Inc Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valeant Pharmaceuticals International Inc Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
Table Valeant Pharmaceuticals International Inc Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
Table Medigus Ltd Company Details
-
Table Medigus Ltd Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Medigus Ltd Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
Table Medigus Ltd Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
Table Pfizer Inc Company Details
-
Table Pfizer Inc Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
Table Pfizer Inc Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
Table AstraZeneca PLC Company Details
-
Table AstraZeneca PLC Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca PLC Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
Table AstraZeneca PLC Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
Table Johnson & Johnson Company Details
-
Table Johnson & Johnson Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
Table Johnson & Johnson Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
Table Mederi Therapeutics Inc Company Details
-
Table Mederi Therapeutics Inc Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mederi Therapeutics Inc Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
Table Mederi Therapeutics Inc Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
Table EndoStim Inc Company Details
-
Table EndoStim Inc Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table EndoStim Inc Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
Table EndoStim Inc Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
Table Medtronic Inc Company Details
-
Table Medtronic Inc Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Medtronic Inc Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
Table Medtronic Inc Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
Table EndoGastric Solutions Inc Company Details
-
Table EndoGastric Solutions Inc Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table EndoGastric Solutions Inc Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
Table EndoGastric Solutions Inc Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
Table Novartis AG Company Details
-
Table Novartis AG Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
Table Novartis AG Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
Table Takeda Pharmaceutical Company Limited Company Details
-
Table Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
Table Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
Table Teva Pharmaceuticals Industries Limited Company Details
-
Table Teva Pharmaceuticals Industries Limited Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceuticals Industries Limited Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
Table Teva Pharmaceuticals Industries Limited Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
Table GlaxoSmithKline Plc Company Details
-
Table GlaxoSmithKline Plc Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Plc Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
Table GlaxoSmithKline Plc Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
Table Boston Scientific Corporation Company Details
-
Table Boston Scientific Corporation Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boston Scientific Corporation Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
Table Boston Scientific Corporation Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
Table Torax Medical Company Details
-
Table Torax Medical Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Torax Medical Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
Table Torax Medical Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
Table Jeil pharmaceutical Co Ltd Company Details
-
Table Jeil pharmaceutical Co Ltd Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jeil pharmaceutical Co Ltd Gastro Esophageal Reflux Disease Drug and Devices Main Business and Markets Served
-
Table Jeil pharmaceutical Co Ltd Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
-
Figure Global Medigus Ultrasonic Surgical Endostapler Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global LINX Management System Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Stretta Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bravo Reflux Testing System Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Digitrapper Reflux Testing System Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast by Country (2022-2028)
-
Table North America Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast by Country (2022-2028)
-
Figure United States Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast by Country (2022-2028)
-
Figure Germany Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast by Country (2022-2028)
-
Figure China Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast by Country (2022-2028)
-
Figure Brazil Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast by Country (2022-2028)
-
Figure Australia Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Gastro Esophageal Reflux Disease Drug and Devices Consumption Forecast and Growth Rate (2022-2028)
-
